The Massachusetts Psychosis Network for Early Treatment (MAPNET) and the New England Mental Health Technology Transfer Center (MHTTC) will host a virtual monthly “Early Psychosis Prescriber Consultation Series” led by Dr. Matcheri Keshavan on prescribing practices for early psychosis, including a review of a selected monthly topic. Our next call is on Monday, July 1st from 11am-12pm EST. Our topic for this month is “Long Acting Injectables” and will be presented by Dr. Raúl Condemarín.

Dr. Raúl Condemarín is a psychiatrist with many years of experience as a psycho-pharmacologist and psychotherapist. He is board certified in Psychiatry, Addiction Medicine, Psychosomatic Medicine and Psychoanalysis. His main areas of expertise are: psychopharmacology, anxiety and mood disorders, and substance abuse disorders. He has conducted research and published in the areas of addiction, psychodynamic psychopharmacology, and the relationship between medical and psychiatric disorders. Dr. Condemarín holds an appointment as Clinical Instructor in the Department of Psychiatry at Harvard Medical School through his affiliation with Massachusetts Mental Health Center, where he teaches and supervises medical students and residents. He is Editor and Trustee of the American Academy of Psychoanalysis and Dynamic Psychiatry. He is fluent in English, Spanish and Portuguese.

Attendees are invited to bring deidentified case questions to discuss with the group. Cases do not have to relate to the monthly topic but should be focused on prescribing issues in early psychosis care.

Attendance will be limited to 20 participants and will be on a first come, first serve basis.